Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Vir Biotechnology, Inc. - Common Stock
(NQ:
VIR
)
6.820
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EST, Jan 14, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Vir Biotechnology, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
14
15
Next >
Vir Biotechnology to Present at J.P. Morgan 2024 42nd Annual Healthcare Conference
December 06, 2023
From
Vir Biotechnology, Inc.
Via
Business Wire
7 Small-Cap Stocks to Buy BEFORE the Year-End Rally
↗
November 30, 2023
explore and wager on these top small-cap stocks to buy, poised for significant gains in today's dynamic global economy
Via
InvestorPlace
From laggards to leaders: Small caps on the rise
November 27, 2023
Despite large-cap dominance, signs suggest a shift to small-cap leadership. Valuations, positive Q3 results, and historical patterns point to potential gains.
Via
MarketBeat
Vir Biotechnology to Present New Data from Its Ongoing Phase 2 Chronic Hepatitis Delta and B Trials Today at AASLD’s The Liver Meeting® 2023
November 13, 2023
From
Vir Biotechnology, Inc.
Via
Business Wire
What 8 Analyst Ratings Have To Say About Vir Biotechnology
↗
September 08, 2023
Via
Benzinga
Is Vir Biotechnology Stock a Buy?
↗
August 11, 2023
The biotech is out to prove that it isn't just a "pandemic stock."
Via
The Motley Fool
Vir Biotechnology to Present Late-Breaking Data from Its Ongoing Phase 2 Chronic Hepatitis B and Delta Trials at AASLD’s The Liver Meeting® 2023
November 10, 2023
From
Vir Biotechnology, Inc.
Via
Business Wire
Vir Biotechnology Ranked the Fastest-Growing Company in North America on the 2023 Deloitte Technology Fast 500™
November 08, 2023
From
Vir Biotechnology, Inc.
Via
Business Wire
Vir Biotechnology Provides Corporate Update and Reports Third Quarter 2023 Financial Results
November 02, 2023
From
Vir Biotechnology, Inc.
Via
Business Wire
Earnings Scheduled For August 3, 2023
↗
August 03, 2023
Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is likely to report quarterly earnings at $1.10 per share on revenue of $512.74 million.
Via
Benzinga
Earnings Scheduled For November 2, 2023
↗
November 02, 2023
Companies Reporting Before The Bell • AudioCodes (NASDAQ:AUDC) is estimated to report quarterly earnings at $0.18 per share on revenue of $61.52 million.
Via
Benzinga
Vir Biotechnology Appoints Jennifer Towne, Ph.D., as Executive Vice President and Chief Scientific Officer
October 30, 2023
From
Vir Biotechnology, Inc.
Via
Business Wire
3 Bill Gates Stocks to Buy for Billionaire-Like Returns
↗
October 27, 2023
Microsoft and Berkshire Hathaway are the two most popular Bill Gates stocks. Investors know these three others far less.
Via
InvestorPlace
7 Biotech Stocks to Get In Now Before Investors Catch On
↗
October 23, 2023
Biotech stocks are down, but there are hidden gems among the rubble. Get in now before the broader market finds them.
Via
InvestorPlace
Vir Biotechnology to Participate in the H.C. Wainwright 4th Annual Hepatitis B Virus (HBV) Conference
October 12, 2023
From
Vir Biotechnology, Inc.
Via
GlobeNewswire
Vir Biotechnology Announces Multiple Abstracts Highlighting New Chronic Hepatitis B and Hepatitis Delta Data Accepted for Presentation at AASLD’s The Liver Meeting® 2023
October 11, 2023
From
Vir Biotechnology, Inc.
Via
GlobeNewswire
Vir Biotechnology to Provide Business Update and Report Third Quarter 2023 Financial Results on November 2, 2023
October 05, 2023
From
Vir Biotechnology, Inc.
Via
GlobeNewswire
Vir Biotechnology Awarded BARDA Funding to Support Development of Antibody Platform Technologies for Global Infectious Disease Threats
October 03, 2023
From
Vir Biotechnology, Inc.
Via
GlobeNewswire
Biden's Urgent Action Against Antibiotic-Resistant Bacteria - Allocates $100M to Battle Deadly Superbugs
↗
September 27, 2023
U.S. President Joe Biden is set to unveil a $100 million research initiative to tackle the growing threat of drug-resistant bacteria. More than a million people worldwide succumb to infections caused...
Via
Benzinga
Stocks That Hit 52-Week Lows On Thursday
↗
September 21, 2023
During the session on Thursday, 461 stocks hit new 52-week lows.
Via
Benzinga
Vir Biotechnology Announces First Participant Dosed in New Phase 1 Trial Evaluating VIR-1388, an Investigational T Cell Vaccine for the Prevention of HIV
September 20, 2023
From
Vir Biotechnology, Inc.
Via
GlobeNewswire
Infectious Disease Player Vir Biotech Has Limited Near Term Upside, Analyst Downgrades
↗
September 08, 2023
BofA Securities has downgraded Vir Biotechnology Inc (NASDAQ: VIR) to Neutral from Buy with a price target of $14,
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 8, 2023
↗
September 08, 2023
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
↗
September 08, 2023
Friday's session saw 225 companies set new 52-week lows.
Via
Benzinga
Planet Labs PBC, GameStop And Other Big Stocks Moving Lower In Friday's Pre-Market Session
↗
September 08, 2023
U.S. stock futures traded lower this morning on Friday. Here are some big stocks recording losses in today’s pre-market trading session.
Via
Benzinga
Stocks That Hit 52-Week Lows On Thursday
↗
September 07, 2023
On Thursday, 283 companies set new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
↗
September 05, 2023
On Tuesday morning, 164 companies achieved new lows for the year.
Via
Benzinga
Vir Biotechnology to Participate in Upcoming Investor Healthcare Conferences
August 29, 2023
From
Vir Biotechnology, Inc.
Via
GlobeNewswire
Vir Biotechnology Provides Corporate Update and Reports Second Quarter 2023 Financial Results
August 03, 2023
From
Vir Biotechnology, Inc.
Via
GlobeNewswire
Vir Biotechnology to Provide Business Update and Report Second Quarter 2023 Financial Results on August 3, 2023
July 26, 2023
From
Vir Biotechnology, Inc.
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
7
8
9
...
14
15
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
